Crosslinked vs non-crosslinked HA
This page places verifiable specifications side by side. It does not rank materials, score them, or recommend one over another.
Comparison
What is the difference between crosslinked and non-crosslinked hyaluronic acid?
The molecule is the same. The difference is a manufacturing step: whether the hyaluronan chains were chemically linked into a network. That single step decides whether the material holds shape, how long it resists enzymatic clearance, and which questions are worth asking about it. It also separates them regulatorily in the United States, where the dermal implant approvals traceable in public records are for crosslinked products.
| Aspect | Crosslinked HA | Non-crosslinked HA | Basis |
|---|---|---|---|
| Molecule | Hyaluronan | Hyaluronan | — |
| Manufacturing step that differs | Chemically crosslinked into a hydrogel network | No crosslinking; remains a solution | — |
| Physical behaviour described | Holds shape and carries load; rheology, in particular elastic modulus, is used to differentiate products | Does not hold shape; delivered in small aliquots across an area | — |
| Reported residence | Extended, attributed in the literature to the network resisting enzymatic degradation | Shorter, no network to resist clearance | — |
| Question the literature asks | Firmness, cohesivity, duration | Distribution, hydration, treatment interval | — |
| Removability | Degradable by hyaluronidase | Cleared without intervention | — |
| Regulatory identity — Korea and EU | Medical device | Not established from public sources | Legal text |
| Regulatory identity — United States | Device pathway; dermal implant approvals traceable from PMA P020023 onward | Not established; no equivalent record found for a non-crosslinked preparation | Legal text |
| Highest-tier evidence cited on this site | Review and laboratory characterisation | Randomised controlled trial of one formulation (PMID 37577796) | — |
One manufacturing step, two categories
It is unusual for a whole product category to be defined by a single processing step applied to an identical starting material. That is the situation here. Everything downstream — how the product is injected, what it is used for, how long it lasts, how it is regulated in at least one market — follows from whether the chains were linked.
The evidence tiers run opposite to expectation
Crosslinked fillers are the larger and older category, but the citations on this site place a randomised trial on the non-crosslinked side and review-level work on the crosslinked side. This is a statement about which studies were published and indexed, not about which material is more established in practice. Read the tier as information about the literature, not about the product.
Where this sits in the atlas
Both entries are on the supply side of the division this reference is organised around: hyaluronan is a native matrix component and injecting it adds matrix. The polyester and ceramic biostimulators sit on the other side, supplying nothing and provoking the host instead. A reader weighing a hyaluronan product against a biostimulator is comparing across that division and should expect the questions to change, not just the answers.
Limitations & open questions
No study cited here places the two in one protocol. The evidence tiers are not symmetric and not in the direction the categories might suggest: the non-crosslinked entry has a randomised trial among its citations while the crosslinked entry is supported by review and rheology work. That reflects what has been published, not a difference in how well established each material is. Products in both categories vary in molecular weight, concentration and added components, so category-level statements should not be carried onto a specific product without checking the formulation.